CLINICAL RESEARCH: HEART FAILURE
The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure
Jeptha P. Curtis, MD*,
Seth I. Sokol, MD*,
Yongfei Wang, MS*,
Saif S. Rathore, MPH*,
Dennis T. Ko, MD*,
Farid Jadbabaie, MD*,
Edward L. Portnay, MD*,
Stephen J. Marshalko, MD, PhD*,
Martha J. Radford, MD, FACC* and
Harlan M. Krumholz, MD, SM, FACC*  ,*
* Section of Cardiovascular Medicine, Department of Internal Medicine and Section of Health Policy and Administration, Yale University School of Medicine, New Haven, Connecticut, USA
Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut, USA
Yale-New Haven Hospital Center for Outcomes Research and Evaluation, New Haven, Connecticut, USA
Yale-New Haven Health Center for Outcomes Research and Evaluation, New Haven, Connecticut, USA
Manuscript received February 24, 2003;
revised manuscript received March 28, 2003,
accepted April 8, 2003.
* Reprint requests and correspondence: Dr. Harlan M. Krumholz, Yale University School of Medicine, 333 Cedar Street, PO Box 208025, New Haven, Connecticut 06520-8025, USA.
harlan.krumholz{at}yale.edu
OBJECTIVES: The aim of this study was to assess the prognostic importance of left ventricular ejection fraction (LVEF) in stable outpatients with heart failure (HF).
BACKGROUND: Although LVEF is an accepted prognostic indicator of prognosis in HF patients, the relationship of LVEF and mortality across the full spectrum of LVEF is incompletely understood.
METHODS: We examined the association of LVEF and outcomes among 7,788 stable HF patients enrolled in the Digitalis Investigation Group trial.
RESULTS: During mean follow-up of 37 months, mortality was substantial in all LVEF groups (range, LVEF  15%, 51.7%, LVEF > 55%, 23.5%). Among patients with LVEF 45%, mortality decreased in a near linear fashion across successively higher LVEF groups (LVEF < 15%, 51.7%; LVEF 36% to 45%, 25.6%; p < 0.0001). This association was present after multivariable adjustment, although the magnitude of this associated risk was reduced (LVEF 15%: hazard ratio [HR] 1.77, 95% confidence interval [CI] 1.48 to 2.11; LVEF 16% to 25%: HR 1.44, 95% CI 1.28 to 1.61; LVEF 26% to 35%: HR 1.10, 95% CI 0.98 to 1.28; LVEF 36% to 45%: referent). In contrast, mortality rates were comparable among patients with LVEF > 45% both before (LVEF 46% to 55%: 23.3%; LVEF > 55%: 23.5%; p = 0.25), and after multivariable adjustment (LVEF 46% to 55%: HR 0.92, 95% CI 0.77 to 1.10; LVEF > 55%: HR 0.88, 95% CI 0.71 to 1.09; LVEF 36% to 45%: referent). Patients with lower LVEF were at increased absolute risk of death due to arrhythmia and worsening HF, but these were leading causes of death in all LVEF groups.
CONCLUSIONS: Among HF patients in sinus rhythm, higher LVEFs were associated with a linear decrease in mortality up to an LVEF of 45%. However, increases above 45% were not associated with further reductions in mortality.
|
Abbreviations and Acronyms
| | BMI | = body mass index | | DIG | = Digitalis Investigation Group | | ERNA | = equilibrium radionuclide angiography | | HF | = heart failure | | LVEF | = left ventricular ejection fraction | | MI | = myocardial infarction |
|
This article has been cited by other articles:
|
|
|
|
 
J. B. Somaratne, C. Berry, J. J.V. McMurray, K. K. Poppe, R. N. Doughty, and G. A. Whalley
The prognostic significance of heart failure with preserved left ventricular ejection fraction: a literature-based meta-analysis
Eur J Heart Fail,
September 1, 2009;
11(9):
855 - 862.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G.-Y. Cho, T. H. Marwick, H.-S. Kim, M.-K. Kim, K.-S. Hong, and D.-J. Oh
Global 2-dimensional strain as a new prognosticator in patients with heart failure.
J. Am. Coll. Cardiol.,
August 11, 2009;
54(7):
618 - 624.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Stellos, B. Bigalke, H. Langer, T. Geisler, A. Schad, A. Kogel, F. Pfaff, D. Stakos, P. Seizer, I. Muller, et al.
Expression of stromal-cell-derived factor-1 on circulating platelets is increased in patients with acute coronary syndrome and correlates with the number of CD34+ progenitor cells
Eur. Heart J.,
March 1, 2009;
30(5):
584 - 593.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. A. Koplan and W. G. Stevenson
Ventricular Tachycardia and Sudden Cardiac Death
Mayo Clin. Proc.,
March 1, 2009;
84(3):
289 - 297.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. M. Henkel, M. M. Redfield, S. A. Weston, Y. Gerber, and V. L. Roger
Death in Heart Failure: A Community Perspective
Circ Heart Fail,
July 1, 2008;
1(2):
91 - 97.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B G. Svealv, E L Olofsson, and B Andersson
Ventricular long-axis function is of major importance for long-term survival in patients with heart failure
Heart,
March 1, 2008;
94(3):
284 - 289.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. S. Chugh, K. Reinier, and E. C. Stecker
Learning From a Real-World Analysis of Implantable Cardioverter-Defibrillator Recipients: Comorbidities Matter
J. Am. Coll. Cardiol.,
June 26, 2007;
49(25):
2416 - 2418.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Patel and J. T. Heywood
Mode of Death in Patients With Systolic Heart Failure
Journal of Cardiovascular Pharmacology and Therapeutics,
June 1, 2007;
12(2):
127 - 136.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J.-M. Tartiere, D. Logeart, F. Beauvais, C. Chavelas, L. Kesri, J.-Y. Tabet, and A. Cohen-solal
Non-invasive radial pulse wave assessment for the evaluation of left ventricular systolic performance in heart failure
Eur J Heart Fail,
May 1, 2007;
9(5):
477 - 483.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A.-Y. Chong and G. Y.H. Lip
Viewpoint: The prothrombotic state in heart failure: A maladaptive inflammatory response?
Eur J Heart Fail,
February 1, 2007;
9(2):
124 - 128.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Cannesson, M. Tanabe, M. S. Suffoletto, D. M. McNamara, S. Madan, J. M. Lacomis, and J. Gorcsan III
A Novel Two-Dimensional Echocardiographic Image Analysis System Using Artificial Intelligence-Learned Pattern Recognition for Rapid Automated Ejection Fraction
J. Am. Coll. Cardiol.,
January 16, 2007;
49(2):
217 - 226.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. E. Owan, D. O. Hodge, R. M. Herges, S. J. Jacobsen, V. L. Roger, and M. M. Redfield
Trends in prevalence and outcome of heart failure with preserved ejection fraction.
N. Engl. J. Med.,
July 20, 2006;
355(3):
251 - 259.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Ahmed, I. B. Aban, M. T. Weaver, W. S. Aronow, and J. L. Fleg
Serum digoxin concentration and outcomes in women with heart failure: A bi-directional effect and a possible effect modification by ejection fraction
Eur J Heart Fail,
June 1, 2006;
8(4):
409 - 419.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. M. Krumholz, Y. Wang, J. A. Mattera, Y. Wang, L. F. Han, M. J. Ingber, S. Roman, and S.-L. T. Normand
An Administrative Claims Model Suitable for Profiling Hospital Performance Based on 30-Day Mortality Rates Among Patients With Heart Failure
Circulation,
April 4, 2006;
113(13):
1693 - 1701.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C Berry, K Hogg, J Norrie, K Stevenson, M Brett, and J McMurray
Heart failure with preserved left ventricular systolic function: a hospital cohort study
Heart,
July 1, 2005;
91(7):
907 - 913.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. G. Ray, Y. Gong, K. Sykora, and J. V. Tu
Statin Use and Survival Outcomes in Elderly Patients With Heart Failure
Arch Intern Med,
January 10, 2005;
165(1):
62 - 67.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Deswal, N. J. Petersen, J. Souchek, C. M. Ashton, and N. P. Wray
Impact of race on health care utilization and outcomes in veterans with congestive heart failure
J. Am. Coll. Cardiol.,
March 3, 2004;
43(5):
778 - 784.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
